Goldman Sachs is adjusting the terms of a $3.75 billion debt package designed to finance Arclin’s acquisition of DuPont’s Aramids business, shifting towards a greater reliance on bond financing amid…
You can read the full story here: Goldman Sachs Considers Arclin Loan Restructuring | $1.73B Leveraged Debt .